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Abstract
Background: Women with highly penetrant BRCA mutations have a 55–60% lifetime risk for breast cancer and a
16–59% lifetime risk for ovarian cancer. However, penetrance differs interindividually, indicating that environmental
and behavioral factors may modify this risk. These include lifestyle factors such as physical activity status, dietary
habits, and body weight. The modification of penetrance by changing lifestyle factors has not thus far been
investigated in a randomized trial in BRCA mutation carriers.
Methods: Therefore, we intend to enroll 60 BRCA1/2 mutation carriers in a pilot feasibility study (Lifestyle Intervention
Study in Women with Hereditary Breast and Ovarian Cancer (LIBRE) pilot). This multi-center, prospective, controlled trial
aims to randomize (1:1) participants into a (1) multi-factorial lifestyle intervention group (IG) versus (2) the control
group with usual care (CG). The primary endpoint is feasibility and acceptance of a structured interdisciplinary lifestyle
intervention program over 12 months (at least 70% of the patients to complete the 1-year intervention). Furthermore,
the effects on physical fitness, BMI, quality of life, and stress coping capacity will be investigated.
During the first 3 months, women in the IG will receive structured, individualized and mainly supervised endurance
training of ≥18 MET*h/week (MET =metabolic equivalent task) and personal nutritional counseling based on the
Mediterranean diet. During the subsequent 9 months, the IG will receive monthly group training sessions and regular
telephone contacts for motivation, whereas the CG will only receive usual care (one general counseling on healthy
nutrition and benefits of regular physical activity on health status). At randomization and subsequent time points (3, 6,
12 months), cardiopulmonary fitness will be assessed by spiroergometry and nutritional and psychological status by
validated questionnaires.
Discussion: This pilot study will investigate the optimal strategy to improve physical fitness, nutritional habits, and
psychological factors in women at high risk for developing breast or ovarian cancer. The results of this pilot feasibility
study will be the basis for a larger prospective randomized trial including clinical events (LIBRE).
Trial registration: ClinicalTrials.gov, NCT02087592
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Background
Tumor suppressor genes, such as breast cancer (BRCA)1
and 2, are important regulators for suppressing tumor
development. Women with highly penetrant BRCA mu-
tations have a lifetime risk of 55–60% for breast cancer
and 16–59% for ovarian cancer [1, 2]. Penetrance rates
vary because of endogenous factors, such as gene poly-
morphisms, as well as exogenous factors, such as the
number of pregnancies, year of birth, and physical activ-
ity during youth [3, 4]. The risk for breast cancer is
lower if genotype carriers were born before 1940, gave
birth, or were physically active during their youth [5, 6].
Prospective studies have revealed that regular physical
activity can significantly reduce breast cancer incidence
in post- and premenopausal women, the risk being re-
duced on average by 25% [7]. Furthermore, the risks of
recurrence and mortality in women with breast cancer
are reduced by 50% if they engage in regular physical ac-
tivity [8]. Further advantages of physical activity include
a gain in quality of life, increased fitness, and improved
tolerance of chemotherapy [9].
Nutrition also influences the risk of breast cancer.
Obesity and weight gain increase the risk of breast can-
cer in both pre- and postmenopausal subjects [10, 11]. A
weight gain of more than 20 kg after the age of 18 dou-
bles the risk of breast cancer. Furthermore, women with
a body mass index (BMI) of >30 kg/m2 have a greater
risk of developing distant metastases and early mortality
[12]. In a prospective study with sporadic breast cancer
on patients under adjuvant standard therapy, a calorie
and fat-reduced nutrition program led to a significant
reduction in recurrence rates [13].
Further risk factors for breast cancer include depres-
sion, a pessimistic outlook on life, and problems in
coping with stress [14, 15]. Numerous studies have over-
whelmingly documented the substantial significance of
an optimistic life perspective for different psychological
and somatic disorders [16]. A positive association was
shown between an optimistic outlook on life and psy-
chological well-being, health, stress reduction, and mor-
tality, as well as improved recovery rates [17–19].
So far, no studies have been performed prospectively
assessing lifestyle intervention in women with hereditary
breast cancer or women with a deleterious BRCA muta-
tion. Even retrospective data analysis is rare. There is
currently only one publication on this subject by
Manders et al. in 2011 [20], which reports on an associ-
ation between increased body weight and an increased
risk for breast cancer in BRCA1/2 mutation carriers.
Therefore, we aim to perform a large randomized
intervention trial assessing whether a long-term multi-
factorial lifestyle intervention program, including (1) a
structured physical endurance training, (2) nutritional
counseling stressing the Mediterranean dietary pattern,
and (3) stress coping strategies, will lead to a reduction
in breast cancer incidence and mortality in BRCA1 and
2 mutation carriers (Lifestyle Intervention Study in
Women with Hereditary Breast and Ovarian Cancer
(LIBRE)). Before this large trial can be started, we will
execute a feasibility study (LIBRE-pilot), which is out-
lined here. This smaller trial with 60 patients will evalu-
ate whether women will be compliant and will
sufficiently adhere to a demanding intervention pro-
gram. Based on the results of this first pilot trial, we aim
to set up a subsequent larger trial to investigate the effi-
cacy of the intervention on clinical endpoints. The
present paper describes the objectives and design of the
feasibility trial, hereafter shortly referred to as “LIBRE-1”
(Lifestyle Intervention Study in Women with Hereditary
Breast and Ovarian Cancer, 1 = pilot).
Methods
Trial design
LIBRE-1 will be a multicenter, prospective, two-armed
randomized (1:1) controlled clinical trial including n = 60
BRCA1 or 2 carriers. The aim of the study is to evaluate
adherence to and acceptance of a structured, 1-year exer-
cise program combined with a Mediterranean dietary pat-
tern in BRCA mutation carriers. Additionally, physical
fitness, body weight, quality of life, and stress coping cap-
acity will be assessed. The study design is outlined in Fig. 1
and includes four visits (study entry (SE), start of interven-
tion (V0), 3 months after start of intervention (V1), and
12 months after start of intervention (V2)). The schedule
of enrollment, interventions, and assessments is shown in
Table 1.
Participants
The goal is to recruit a minimum of 60 patients for the
feasibility study. Recruitment and study conduct take
place at three centers in three different regions in
Germany (Munich, Kiel, and Cologne). Patients will be
recruited from the German Consortium Hereditary
Breast and Ovarian Cancer (GC-HBOC), a national
registry for BRCA1 and 2 carriers. BRCA1- or 2-positive
participants have been included in this surveillance pro-
gram before and are contacted on a regular basis regard-
ing clinical events. They have previously received genetic
analysis mainly because of an amplified family history
for breast cancer. They have received additional counsel-
ing before and are aware of their cancer lifetime risks.
Table 2 details the study’s inclusion and exclusion cri-
teria. Contacting the carriers for potential inclusion in
the LIBRE-1 study will be done by the local study cen-
ters which are familiar with the patient history. Patients
will either be contacted by telephone or during their
regular visits to the hospital. Information regarding the
LIBRE-1 trial will be given in person by physicians
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Fig. 1 Design of the trial
Table 1 Schedule of enrolment, interventions, and assessments
Enrolment Start 3 months 6 months 9 months 12 months 24 months 36 months +12 months






Intervention group (I) X X X X X X X X X
Control group (C) X X X X X X
Assessments
Clinical baseline C + I
Clinical follow up C + I C + I C + I C + I
Spiroergometry C + I C + I C + I
Accelerometry C + I C + I C + I C + I C + I
Questionnaire “training” (IPAQ-L) C + I C + I C + I C + I C + I C + I C + I
Questionnaire “nutrition”
(MEDAS, EPIC-FFQ)
C + I C + I I I C + I C + I C + I
Lab C + I C + I C + I C + I C + I
Clinical examination C + I C + I C + I C + I C + I
Anthropometry C + I C + I C + I C + I C + I
Psychological questionnaires C + I C + I C + I C + I C + I
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involved in the GC-HBOC program and previously
instructed regarding the LIBRE-1 study. If patients agree
to participate in the trial, they will have to sign consent
forms and, if eligible, will be enrolled into the trial.
Intervention
Intervention group
The intervention program group is designed to last
12 months. The first 3 months includes intensive
(regular) contact with physical activity and nutritional
education sessions. The learned strategies will then be
maintained and monitored in the following 9 months
through monthly contacts and meetings. The lifestyle
intervention program comprises the following measures:
1. Physical activity: The LIBRE training program is
primarily an endurance-oriented training, which
will be completed in the course of 1 year. After a
mandatory introductory lecture on the theory
behind the intervention training, the goal is to
increase physical activity to ≥18 MET*h/week
(MET =metabolic equivalent task). One MET is
equivalent to resting energy expenditure, so multiple
METs express exercise intensity that is performed
over a certain time, e.g., hours per week. 18 MET*h/
week is approximately equivalent to brisk walking
(4.5 MET) for 4 h per week. This activity level
has been correlated consistently with a reduction
of morbidity and mortality in breast cancer patients
[8, 21]. This goal should be achieved within the first
12 weeks and maintained throughout the whole study
period. Each subject will receive an individual training
plan, which will continuously be adapted according to
her fitness status. The training plan is divided into two
phases: the intensity of the initial phase, weeks 1–6,
should be at least 50–60% of the peak oxygen
consumption (VO2 peak), and the optimization
phase, weeks 7–12, 60–75% of the VO2 peak. In
the first 12 weeks of the intervention program,
training will take place twice a week as supervised
training and once a week as home-based training
(HBT). Afterwards, supervised training units will
only be carried out monthly, so that training in
months 4–12 will be mainly HBT. Training will
continue to take place with an intensity of at least
60–75% of the VO2 peak in accordance with the
individual training plan.
A record of compliance with the training intervention
program as well as the achieved MET*h/week will be
kept in the training diaries (questionnaire on physical
activity, V0–V2). Participants should record their daily
activities as well as intentional physical activity
including intensity and duration of training. The
training intensity levels will then be assessed by
spiroergometry and outlined in the diary, which
facilitates training control. Monthly supervised
training units (as of V1) offer the opportunity to
realign training intensity and discuss any problems
with adherence to training. In addition, physical
activity is to be recorded using questionnaires
(International Physical Activity Questionnaire
(IPAQ) [22, 23] from V0 to V2), motion sensors
(accelerometer from SE to V2), and a physical
fitness assessment by cardiopulmonary exercise
testing by spiroergometry (VO2 peak) [24] at time
points SE, V1, and V2.
2. Nutrition: Within the framework of the LIBRE-1
study, the nutrition intervention is based on the
principles of a Mediterranean dietary pattern (MD).
Furthermore, obese patients (BMI ≥ 35 kg/m2) will
be instructed to limit their energy (kcal) intake.
Nutrition intervention in the IG consists of an
intensive phase of 3 months in line with the intensive
physical exercise program. During this phase,
bi-weekly nutrition education group courses will be
held by dietitians. They include a cooking class and
guided tour of a supermarket. Afterwards, nutrition
courses will be reduced to monthly intervals. The
main objective of the nutrition intervention is to
provide practical nutritional training, which should
enable the subjects to achieve a long-term change in
their eating habits, replacing it with the MD. Eating
habits will be recorded using validated questionnaires
(EPIC-Food Frequency Questionnaire (FFQ) and
Mediterranean Diet Adherence Screener (MEDAS))
at the time points SE, V1, and V2. The questionnaires
are described below in the “Measurements” section.
Table 2 Study population: inclusion and exclusion criteria
Inclusion criteria (all criteria must apply):
• Women with a pathogenic BRCA1 or BRCA2 germline mutation
• Age between 18 and 69 years
• Written informed consent
Exclusion criteria:
• Metastatic tumor disease
• Expectancy of life <3 years
• Limited cardiovascular and lung diseases (instable CHC, heart failure
stage IV, COPD GOLD IV, maximal blood pressure at rest >160/
100 mmHg)
• Significant orthopedic problems, not allowing exercise
• Serious diseases, not allowing a participation in group interventions
(e.g., psychiatric or internal ailment)
• Karnofsky status scale <60%
• Women with VO2 max > 150% of general population
• Women with an exercise capacity <50 W
• Food allergies not allowing consumption of a Mediterranean dietary
pattern
• Vegans
• BMI < 15 kg/m2
• Pregnancy
• Insufficient knowledge of the German language
• Current participation in other lifestyle intervention trials
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3. Psychological support: Explicit psychological support
is not planned. Psychological support of the IG will
comprise solely of an explanation of the psychological
data survey questionnaires given to the study
participants. The participants will be informed that
the objective of the lifestyle study is, among others,
that the lifestyle change including regular physical
activity and healthy eating should lead to an
improvement in general life quality, stress reduction,
and a more optimistic outlook on life. In order to
verify this, the participants will receive questionnaires
(Screening Scale for Chronic Stress (SSCS), Life of
Orientation Test-Revised (LOT-R), European
Organisation for Research and Treatment of Cancer
(EORTC) Quality of Life Questionnaire Core 30 and
Breast Cancer Module 23 (QLQ-C30/-BR23), and
Assessment of physical activity and nutrition (BKAE))
at several time points (SE, V0, V1, V2). Advice on the
psycho-oncological aspects of the LIBRE study will be
given during the introduction lecture at the begin-
ning of the study. The psychological advice given
to the study participants will serve to inform the sub-
jects of the significance and improvement of psycho-
social lifestyles for the prevention of breast and ovar-
ian cancer, as well as to promote compliance and
recognize possible psychological impediments for par-
ticipation in the study.
Control group
The CG will receive a mandatory introduction lecture
on the positive effects of physical activity on the inci-
dence and prognosis of breast cancer. Afterwards, all
participants will be given a brochure providing the most
important facts on this topic. In contrary to the IG, no
training and no physical activity diaries will be provided.
Changes in physical activity behavior are however to be
measured identically to the interventional group by
questionnaires (IPAQ from V0 to V2), motion sensors
(accelerometer SE–V2), and examinations of physical ex-
ercise capacity (VO2 peak) at the time points SE, V1,
and V2. Additionally, a dietitian-led group lesson on
healthy eating will be held for the CG/UC. During this
lesson, the subjects will receive general information
based on the recommendations of the German Society
of Nutrition, which is referred to as “usual care in
Germany” in this study. Eating habits will be recorded
identically to the intervention group via validated ques-
tionnaires (EPIC-FFQ and MEDAS questionnaire) at the
defined time points SE, V1, and V2.
Finally, the control group will receive an explanation
of the psychological data entry forms, given to the study
participants. An explicit psycho-oncological intervention
strategy is also not intended in this group. The partici-
pants will be informed that changes in daily routine
concerning physical activity and dietary habits among
other things should result in the improvement of quality
of life, a reduction of stress, and a more optimistic ap-
proach to future life. In order to verify this, the partici-
pants will receive questionnaires (SSCS, LOT-R, EORTC
QLQ-C30/-BR23, LIBA, and BKAE) at SE, V0, and V2.
The psychological information of the CG/UC corre-
sponds to those of the IG.
Measurements
In order to achieve the study goals and to answer the
research questions, structured questionnaires and inter-
view sheets, diaries, clinical and instrument-based exam-
inations, and blood and stool tests will be used.
Medical history
Data will be gathered by means of an interview at SE. In
addition to a basic clinical assessment, pre-existing in-
ternal and gynecological illnesses and general risk and
protective factors such as body weight, alcohol con-
sumption, nutritional behavior, level of activity, and
number of pregnancies will be assessed.
Sociodemographic
Data will be collected at SE. The psychosocial and socio-
economic risk and protective factors such as living con-
ditions, job situation, and income level will be assessed.
Medical radiation exposure
Data will be gathered by means of an interview at SE.
The previous diagnostic and therapeutic X-ray exposure
will be documented.
Study satisfaction questionnaire
This questionnaire will be handed out at V1 and V2.
Questions are intended to capture the subject’s accept-
ance of the study, their satisfaction with the supervision,
an evaluation of the physical activity and nutrition pro-
gram, and their assessment of everyday practicality of
the intervention program, where relevant.
Cardiovascular assessment
Within this examination at time points SE, V1, and V2,
the patient’s medical history will be taken and a clinical
examination with focus on the cardiovascular system
will be performed. A resting electrocardiogram (ECG),
pulmonary function testing, and blood pressure mea-
surements are obligatory. Resting heart rate and blood
pressure are to be recorded as measuring parameters.
Exercise testing/spiroergometry
Spiroergometry is an objective and well-known examin-
ation assessing cardiopulmonary exercise capacity. As
the maximal oxygen uptake (VO2 max) and the aerobic
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and anaerobic respiratory capacity will be measured, the
results enable a precise statement about the maximum
cardiopulmonary capacity as well as aerobic and anaer-
obic capacity. The following target parameters (VO2
peak and O2 at ventilator anaerobic threshold (VAT))
[24] provide information about the fitness level at visits
SE, V1, and V2.
Accelerometer
The AiperMotion 440/500 is a recognized physical activ-
ity meter, which objectively measures the scope of activ-
ity, as well as the steps and speed of movement [25–27].
The device is light (72 g) and has a three-dimensional
digital acceleration sensor, which with an accuracy of
95%, classifies the level of movement into the categories
“active,” “slow walk,” “fast walk,” and “jog.” The average
level of activity is recorded as a physical activity level
(PAL) value. The movement sensors will be distributed
at five different time points in the first study year
(SE–V2).
International Physical Activity Questionnaire
The IPAQ comprises five areas of activity, which are ex-
amined independently of each other [28]. The question-
naire is a simple instrument, which can be used to
collect internationally comparable data for health-
promoting physical activity over the last 7 days. The
IPAQ is to be assessed at all study time points (SE–V2).
Examination of body composition
The examination of physical constitution comprises the
documentation of anthropometric parameters such as
height; body weight; waist, hip, and upper arm measure-
ments; skin fold tests; and the bioelectric impedance
analysis (BIA measurement) at the visits SE, V1, and V2,
respectively. These measurements serve to record the
percentage of body fat and the BMI and to determine
level of lean body mass.
Blood tests
Within the context of the study, various blood values
will be regularly determined (Table 3) in both the study
arms at the time points (SE, V1, V2).
Stool samples
All subjects will provide stool samples (SE, V1, V2). A
collective microbiome and metabolome analysis will be
carried out at a later date.
EPIC-FFQ [29–31]
The questionnaire refers to food consumption during
the last year and covers 148 food items. For each item,
questions are asked concerning the average quantity
consumed (pre-defined servings) and the frequency of
consumption (1–6 times per day, week, month, or year).
Color photos simplify the definition of serving sizes for
food items, which are not consumed in normal house-
hold quantities. Furthermore, respondents are specific-
ally asked about their use of cooking fats/oils, the
frequency of consumption of sauces with meat and fish,
the fat content of the milk they consume, the use of
sugar and milk in coffee and tea, and the seasonal con-
sumption of fresh fruit and vegetables. The data input
and evaluation of the questionnaires is to be carried out
via the study management system (SMS) for health re-
search, which has been developed and is supervised by
the Department of Epidemiology of the German Institute
of Human Nutrition Potsdam-Rehbruecke (DIfE). The
EPIC-FFQ will be conducted at SE, V1, and V2 in both
study arms.
Mediterranean Diet Adherence Screener [32]
The MEDAS questionnaire was developed within the
scope of the PREDIMED study. The evaluated English
version was translated for the LIBRE-1 study and com-
plemented by pictures of serving sizes (cf. CRF MED).
The German version of the MEDAS will be validated within
the scope of the pilot study. The MEDAS questionnaire is to
be conducted at SE, V1, and V2 in both study arms.
Measurement of quality of life (EORTC QLQ-C30/-BR23) [33, 34]
In order to acquire health-related quality of life
(HRQOL), a composed questionnaire, a 30-item core
questionnaire (QLQ-C30), and a 23-item breast can-
cer module (QLQ-BR23) will be used before and after
the intervention period [35]. The advantage of the
QLQ-C30/-BR23 includes the present-day relevance
and the previous validation for breast cancer (QLQ-
BR23). Validation studies in European countries and
the United States have been conducted in cross-
cultural context [36, 37].
Table 3 Blood measurements







• Blood cell count
• HbA1c





• Proencephalin A 119 D159 (Sphingotec GmbH)
• Proneurotensin 1–117 (Sphingotec GmbH)
• hsCRP (high sensitivity CRP)
• Omega-3, 6, and 9 fatty acid content in the membrane of erythrocytes
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Measurement of optimism (life orientation test, ten items,
LOT-R by Glaesmer et al. [38])
The LOT-R was developed to collect individual differ-
ences of generalized optimism versus pessimism in the
form of a personality variable. It has been applied in
various intervention studies, which, among other things,
look at the consequences of dispositional optimism on
behavior, emotion, and physical health. We hypothesize
that regular physical activity and the implementation of
healthy nutrition (IG) can lead to a more optimistic atti-
tude to life.
Measurement of chronic stress [39]
The SSCS by trier inventory on chronic stress is a 12-
item (short version) questionnaire, which measures five
different aspects of chronic stress: lack of social recogni-
tion, pressure of business, social stress, chronic anxiety,
and overstrain [39].
Measurement of attitudes and views on physical exercise
and healthy eating (BKAE, 18 items)
One of the main intentions of the present LIBRE study is
to investigate the practicability of the intervention program
in the sense of good compliance of mutation carriers to-
wards an exercise program and Mediterranean diet. In
order to understand how different factors may influence
compliance, measurements of subjective parameters are
needed (such as attitudes towards a behavior, subjective
norms, and perceived behavior control), which represent a
necessary link between objective factors (age and other
demographics, stage of disease, comorbid conditions, treat-
ments, stress pressure, daily hassles, etc.) and intentions re-
lated to behavior as well behavior itself (doing sports and
keeping a specific diet). According to the theory of planned
behavior (see Fishbein and Ajzen [40]), the intentions re-
lated to behavior result from an interplay between attitudes
towards a behavior, subjective norms, and perceived behav-
ior control. The theory of Fishbein and Ajzen was applied
in the last years in many studies which dealt with health
psychology (e.g., surgery intentions, food adherence, and
physical activity behavior among others) and represents
one of the well-proven ways to investigate subjective mech-
anisms of compliance [41–44]. In the context of the
Fishbein and Ajzen [40] model, the study may answer the
following questions: (1) Which are the predictors of regular
participation in the preventive measures (exercise, nutri-
tion)? (2) To which degree are attitudes, subjective norms,
or perceived behavior control towards a behavior relevant
for the intention of behavior (i.e., to train regularly and to
eat healthy) and for the de facto behavior shown?
Study endpoints
The primary endpoint of the study is the number of
randomized women who successfully complete the
first 3 months of the intervention program and the
monitoring/maintenance phase after 1 year. The study
is considered feasible if at least 70% of the patients
fulfill the criteria (see Table 4 for details).
Secondary endpoints of the study include the measure-
ments of quality of life (EORTC QLQ-C30-/BR23), stress
coping (SSCS), optimism grade (LOT-R), body mass
index (BMI), eating habits, nutrient and fat calorie intake
(EPIC-FFQ), adherence to a Mediterranean diet (MEDAS),
maximal oxygen intake (VO2 max), and physical activity
(IPAQ). These measurements will be performed after 3, 6,
and 12 months of intervention and compared to the base-
line measurements at SE.
Statistical analysis and randomization
The sample size for the feasibility study is to be at
least 60 women. For this study, the sample size was
not determined based on statistical assumptions and
tests, but on practical grounds that each center
should recruit 20 participants. Primary and secondary
endpoints will be analyzed descriptively. The primary
endpoint will be determined according to the criteria
shown in Table 4. Secondary endpoints will be de-
scribed using absolute or relative frequencies, means
with standard deviations, or medians with inter-
quartile ranges as appropriate, for each of the study
arms at the different time points. Measurements at
months 3, 6, and 12 will be compared and tested
against the baseline values using either parametric or
non-parametric tests as appropriate. Randomization is
to take place using envelopes, which will be deposited
at the study center before the study begins. The
group allocation (randomization) will be done cen-
trally, using randomly permuted blocks of length 2–6.
The randomization ratio is to be 1:1. We will use
participating center and previous breast cancer as
stratification factors. Each center will receive consecu-
tively numbered, opaque envelopes, unique to them,
split into two sets (one for previously diseased and
one for healthy participants), containing the results.
For each new participant, the principal investigator in
the center will choose and open the first envelope
from the diseased or healthy batch accordingly. As
the study is not blinded, the allocation result will be
concealed neither from participants nor from the
principle investigators.
Table 4 Criteria for successful completion
Attendance of 70% of the planned lifestyle intervention events
(training sessions and nutrition courses) within the first 3 months
• Conduct of study visit after 1 year
• No withdrawal of informed consent within 1 year
• No new occurrence of any of the exclusion criteria during the first
3 months
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Discussion
To the best of our knowledge, the LIBRE-1 study is the
first prospective randomized lifestyle intervention trial in
BRCA mutation carriers worldwide. Since the patients in
the intervention arm will be given a strict and intensely
structured intervention program, the purpose first is to
assess the feasibility of the study design in a multicenter
setting including 60 female mutation carriers. We are
aware that the study protocol is time-consuming and de-
manding for the patients including regular exercise and
changes in nutritional habits but believe it necessary to
cover/investigate all relevant factors. Especially, during
the first study visit, the questionnaires amount to a large
contribution for the participants. However, the question-
naires can be answered during the waiting time between
the examinations, e.g., spiroergometry, ECG, and body
composition, lasting approximately half a day. In order
to meet a high compliance rate, all participants will be
informed beforehand about the time necessary for study
examinations. For the time spent for examinations, pa-
tients will also receive a small financial reimbursement.
The Mediterranean diet though is widely accepted as a
healthy diet in Germany. In addition, randomized con-
trolled intervention studies have revealed that it is effect-
ive in the primary prevention of cardiovascular diseases
[45], in improving diabetes [46] and cognitive function
[47], and recently also in the primary prevention of inva-
sive breast cancer [48].
Once compliance and acceptance of the study protocol
have been proven (LIBRE-1), we will proceed with a lar-
ger cohort of mutation carriers with the intention to in-
vestigate whether the improvement of physical fitness,
body weight, quality of life, and stress coping capacity
leads to a reduction of breast cancer risk, progression of
disease, and even mortality. On the basis of the LIBRE-1
results, it will be possible to outline a lifestyle program
with high adherence even over 12 months of interven-
tion (LIBRE trial). The current feasibility study will also
reveal barriers to and constraints of the intervention,
which will then have to be modified for the larger clin-
ical trial.
One of the foreseen limitations of the trial will be se-
lection bias for those patients being interested in lifestyle
intervention and for those who will be randomized to
usual care, especially for highly motivated participants.
The latter patients may be disappointed on being
assigned to the control arm and might either withdraw
from the study or follow exercise instructions from the
IG. These biases cannot be excluded in any lifestyle
intervention trial. However, physical activity will be
assessed using questionnaires and an accelerometer in
both arms, and any cross-over of patients can be moni-
tored. In addition, physical fitness will be objectively
assessed by spiroergometry in both arms, which will also
yield information on the long-term involvement of phys-
ical activity.
On the other hand, restraints for less motivated pa-
tients, e.g., due to professional obligations or as cares for
children or other family members, may have an impact
on adherence to supervised exercise sessions and every-
day physical activities. In addition, a cross-over from CG
to IG group for the Mediterranean dietary pattern can-
not be excluded as previously outlined for physical activ-
ity. However, nutritional habits will also be assessed by
questionnaire and BMI and body composition measured
in both groups. Because of these problems in lifestyle
intervention trials, it is a clear aim to avoid cross-over
or bias of investigations by assuring that patients be
treated identically regardless of the group assignment.
This LIBRE initiative (pilot and clinical study) will
have the potential to reveal whether a structured lifestyle
intervention program may prevent tumor incidence in
BRCA mutation carriers. This will have to be compared
with current risk-reducing strategies for women at risk,
including prophylactic mastectomy, and could then be
added to early detection programs. Furthermore, by fol-
lowing a structured exercise program and dietary
changes, mutation carriers will attain an independent
and self-governed role in cancer prevention and success-
fully reduce their stress levels [39]. By improving and
optimizing the latter, we expect a preventive health ef-
fect not only on a somatic but also on the mental status
of these patients.
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